Why do AI and IoT systems increase healthcare security risk?

Why This Matters for Security Teams

AI and IoT increase healthcare security risk because they expand the attack surface while also increasing the number of trust decisions made outside core clinical platforms. AI systems may ingest patient data, generate sensitive outputs, or be embedded in clinical workflows without the same maturity as traditional applications. IoT devices can add weakly governed endpoints, legacy firmware, remote management paths, and third-party dependencies that are difficult to inventory consistently. The result is not just more assets, but more opportunities for data exposure, misconfiguration, and lateral movement.

Security teams often underestimate how quickly these technologies blur the line between operational convenience and security exposure. The issue is not only whether a device or model is “secure,” but whether its data flows, identity bindings, update paths, and human override controls are governed throughout the lifecycle. That is why frameworks such as the NIST Cybersecurity Framework 2.0 remain useful: they force teams to map assets, understand dependencies, and assign accountability across protect, detect, respond, and recover functions. In practice, many healthcare teams discover the risk only after an AI workflow has already surfaced protected information or an IoT device has become the weakest point in a clinical network.

How It Works in Practice

In real healthcare environments, AI and IoT risk usually appears through ordinary operational workflows rather than dramatic failures. AI tools may connect to electronic health record data, imaging repositories, call centers, or clinical documentation systems. If prompt handling, retrieval sources, and output validation are weak, the model can expose sensitive information, amplify hallucinated advice, or provide unauthorized recommendations. IoT devices such as infusion pumps, monitors, badges, cameras, and environmental sensors create parallel risk because they often depend on vendor maintenance, constrained patching windows, and heterogeneous authentication methods.

Good practice starts with asset and data-flow visibility. Teams should know which devices and models exist, what data they touch, who can administer them, and where telemetry goes. For AI systems, this includes training data governance, model provenance, output controls, and monitoring for prompt injection or data exfiltration. For IoT, it includes secure onboarding, device identity, network segmentation, firmware hygiene, and logging that can be consumed by SIEM and incident response workflows. The MITRE ATT&CK knowledge base is useful for thinking through attacker technique chains, while OWASP guidance for large language model applications helps security teams structure AI-specific controls around injection, sensitive data exposure, and insecure tool use.

• Classify AI models and IoT devices by clinical criticality and data sensitivity.
• Bind each system to an accountable owner, patch process, and logging requirement.
• Restrict model inputs, retrieval sources, and device access to the minimum needed.
• Test for prompt injection, unsafe outputs, weak credentials, and unauthorized remote access.
• Route AI and IoT telemetry into monitoring, response, and recovery playbooks.

These controls tend to break down when devices are deployed by departments outside central IT because ownership, patching, and access review become fragmented.

Common Variations and Edge Cases

Tighter control over AI and IoT often increases operational overhead, requiring organisations to balance clinical speed against governance, uptime, and usability. That tradeoff is real in hospitals, where life-support workflows, vendor-managed devices, and research systems may not fit standard change windows or identity processes. Best practice is evolving here, especially for agentic AI and connected medical devices, so some guidance remains policy-driven rather than universally standardised.

Edge cases matter. A model used only for back-office summarisation may be lower risk than one embedded in triage or scheduling, but it can still leak protected data through outputs. Likewise, a device on a segmented biomedical network may still be risky if its telemetry, remote support channel, or shared admin account is poorly governed. Healthcare teams also need to distinguish between tools that merely assist staff and systems that can act with execution authority, because autonomous actions raise the bar for review, logging, and rollback. For broader control mapping, the NIST AI governance approach and zero trust principles align well with healthcare environments that need to reduce implicit trust across both data and devices, not just protect the core network.

For teams building a durable program, the practical question is not whether AI or IoT should be used, but whether each deployment can be continuously inventoried, constrained, monitored, and retired safely when it no longer meets policy or safety requirements.

Related resources from NHI Mgmt Group

• Why do AI-enabled marketing systems increase privacy and security risk at the same time?
• Why do AI systems increase identity risk even when they improve security operations?
• Why do frontier AI systems increase recovery risk for security teams?
• How should security teams limit the risk from AI agents that have access to production systems?